Anthony J. Olszanski, Drew W. Rasco, Manish R. Sharma, Alexander I. Spira, Michael M. Song, Meredith Pelster, Cesar Augusto Perez, Afshin Dowlati, Rachel E. Sanborn, M Wasif Saif, Douglas Adkins, Vincent K. Lam, So Yeon Kim, Joel R. Hecht, Jeffrey J. Raizer, Richard C. Gregory, Cierra N. Casson, Deepak Nag Ayyala, Amy Sexauer, Stephane Champiat. "A phase 1/2, first-in-human, open-label, dose-escalation and -expansion study of TAK-188, a novel antibody-drug conjugate (ADC) targeting CCR8 + regulatory T cells, in adult patients with locally advanced or metastatic solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3155